Urological malignancy in Hong Kong: the trend and the practice

Yee, Chi‐Hang; Ng, Chi‐Fai

doi:10.1093/jjco/hyv145

Cited by 9 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As data have shown, prostate cancer is one of the most common cancers among males in Hong Kong (China) 3. In our study, we observed a statistically significant increase in the diagnosis of prostate cancer.…”

supporting

confidence: 70%

Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades

et al. 2019

View full text Add to dashboard Cite

supporting

confidence: 70%

Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades

et al. 2019

View full text Add to dashboard Cite

“…On the other hand, we had a higher ASR for females than the other five GCC states (Saudi Arabia: 1.7, Oman: 1.9, Qatar: 3.4, Kuwait: 2, and United Arab Emirates: 1.1 per 100,000) [7]. ASR for kidney cancer in Europe, the United States, Korea, Hong Kong, and Taiwan were all higher than that of our population (4.1-31.4 males and 2.1-14.5 females, 17, 5.9, 4.8, 5.32 per 100,000) [8,9]. However, the ASR in China was notably lower (3.35 per 100,000).…”

Section: Discussionmentioning

confidence: 86%

Renal Carcinoma Patterns and Prevalence in Bahrain: A Descriptive Study

Aradi¹,

Rashed²,

Mubarak³

et al. 2022

Cureus

View full text Add to dashboard Cite

Cancer is a major health problem with a significant impact on society and healthcare systems. In 2018, approximately 18.1 million cases of cancer were diagnosed and 9.6 million deaths were documented. Urological cancers account for 12.9% of new cases recorded and 8% of deaths due to cancer worldwide. The latest cancer registries covering the Gulf Cooperation Council (GCC) countries report that 4078 cases of renal cell carcinoma were diagnosed from 1998 to 2012. Urological cancers comprised 9.4% of all cases with an incidence rate of 16.1% in males and 3.2% in females.All renal cancer cases documented in Salmaniya Medical Complex (SMC) from 2014 to 2018 were reviewed. Data collected for all patients from the electronic health record system included age at diagnosis, gender, laterality of cancer (where applicable), histological type, and TNM (tumor, node, metastasis) classification and staging. Furthermore, World Health Organization (WHO) grade and data were collected for kidney cancer cases. Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) version 23 (IBM Corp, Armonk, NY).From 2014 to 2018, there were 65 documented cases of kidney cancer with an average caseload of 13 cases per year. The mean age at diagnosis was 57.6 years. Clear cell carcinoma was the most common histological subtype (37.5%). Stage 1 was the most common stage at diagnosis (35.4%) and the age-standardized mortality rate for males and females were 4.59 and 4.58 in 100,000, respectively. Kidney cancer is a urological malignancy that can pose a burden on both the patient and the healthcare system. There should be a national effort to better understand the etiology and epidemiology of this disease entity with regard to our population. Such efforts would make data regarding diagnosis, management, and follow-up more accessible and would add positively to our healthcare system.

show abstract

“…Urological malignancies are increasing with age, and modifiable risk factors partly influence these cancer 2 . In urological pathology, malignancy is important and constitutes a real public health problem as it is increasing 3,4 . Urological malignancies include cancers of the kidney, ureter, urinary bladder, and urethra in both sex and males and cancers of the prostate, penis, scrotum and testis 4 .…”

Section: Introductionmentioning

confidence: 99%

Current trends in the incidence of Urological malignancy at a tertiary level hospital in the northern part of Bangladesh

Arefin,

Bari,

Islam

et al. 2023

Bang J Urology

View full text Add to dashboard Cite

The second most common cause of death is malignancy. In clinical practice, genitourinary tumours are commonly encountered. Urological malignancies are raising due to increasing tobacco consumption, air and water pollution (arsenic, nitrate, chlorinated hydrocarbon) by unbalanced development, unhealthy diet, chronic infection, uncontrolled pesticides & fungicides used, food adulteration, using Chinese herbal products containing aristolochic acid, obesity and longer life expectancy. Over the past few years, advancement of diagnostic imaging, surgical technique, radiotherapy, chemotherapeutics and targeted agents have helped improve treatment outcomes. The incidence of urological malignancies is increasing like other malignancies in Bangladesh, which is poorly addressed. There is generally poor documentation of urological malignancies in Bangladesh. This study was carried out to document the pattern and distribution of urological malignancies in Rajshahi Medical College, Rajshahi, Bangladesh. Bangladesh J. Urol. 2022; 25(2): 98-105

show abstract

Urological malignancy in Hong Kong: the trend and the practice

Abstract: In Hong Kong, urological malignancy accounted for 9.55% of all the new cases of cancer in 2012. In the male population, prostate cancer was the third most commonly diagnosed cancer, and the fifth leading cause of cancer death. Age-standardized rate of prostate cancer incidence rose from 11

Cited by 9 publications

References 26 publications

Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades

Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades

Renal Carcinoma Patterns and Prevalence in Bahrain: A Descriptive Study

Current trends in the incidence of Urological malignancy at a tertiary level hospital in the northern part of Bangladesh

Contact Info

Product

Resources

About